Renalytix (Reg S) (RENX)

Sector:

Health Care

Index:

FTSE AIM All-Share

24.00p
   
  • Change Today:
    -0.50p
  • 52 Week High: 145.00
  • 52 Week Low: 10.25
  • Currency: UK Pounds
  • Shares Issued: 127.55m
  • Volume: 23,772
  • Market Cap: £30.61m
  • RiskGrade: 348

RENX Overview

RenalytixAI is a developer of artificial intelligence (AI) enabled clinical decision support solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI’s solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care and patient stratification for drug clinical trials.

Key Personnel

CEO: James Renwick McCullough
Chief Technical Officer: Fergus Fleming
Non-Executive Chairman: Christopher H B Mills
Non-Executive Dir: Daniel J. Levangie, Catherine Coste, Erik Kristian Lium

Contact Details

Address: 2 Leman Street, London, United Kingdom, E1W 9US
Website: http://www.renalytix.com/

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BYWL4Y04

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

RENX Market Data

Currency UK Pounds
Share Price 24.00p
Change Today -0.50p
% Change -2.04 %
52 Week High 145.00
52 Week Low 10.25
Volume 23,772
Shares Issued 127.55m
Market Cap £30.61m
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
14.4% below the market average14.4% below the market average14.4% below the market average14.4% below the market average14.4% below the market average
3.23% above the sector average3.23% above the sector average3.23% above the sector average3.23% above the sector average3.23% above the sector average
Price Trend
92.3% below the market average92.3% below the market average92.3% below the market average92.3% below the market average92.3% below the market average
67.57% below the sector average67.57% below the sector average67.57% below the sector average67.57% below the sector average67.57% below the sector average
Income Not Available
Growth
18.47% above the market average18.47% above the market average18.47% above the market average18.47% above the market average18.47% above the market average
27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average

RENX Dividends

No dividends found

Trades for 29-Apr-2024

Time Volume / Share Price
16:18 10,000 @ 24.00p
15:21 6,259 @ 23.90p
13:59 279 @ 23.25p
12:04 5,000 @ 23.00p
11:29 93 @ 25.00p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page